PROTECT PHARMACEUTICAL Corp: 10-Q filed 2016-05-23

Name: PROTECT PHARMACEUTICAL Corp: 10-Q filed 2016-05-23
Creator: PROTECT PHARMACEUTICAL Corp

What PROTECT PHARMACEUTICAL Corp reported in its quarterly report filed 2016-05-23 (fiscal Q1 2016): 13 published measures, 28 facts as tagged in accession 0001551163-16-000419.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-05-23
Fiscal period: fiscal Q1 2016
Accession: 0001551163-16-000419 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PROTECT PHARMACEUTICAL Corp filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-03-31	15	USD
At 2015-12-31	7	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-03-31	102,634	USD
At 2015-12-31	100,454	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2016-03-31	-102,619	USD
At 2015-12-31	-100,447	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-03-31	15	USD
At 2015-12-31	7	USD
At 2015-03-31	357	USD
At 2014-12-31	502	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	-3,672	USD	91
2015-01-01 to 2015-03-31	-5,582	USD	90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	8	USD	91
2015-01-01 to 2015-03-31	-145	USD	90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-03-31	-9,353,964	USD
At 2015-12-31	-9,350,292	USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-03-31	15	USD
At 2015-12-31	7	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-03-31	102,634	USD
At 2015-12-31	100,454	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2016-03-31	9,245,788	USD
At 2015-12-31	9,244,288	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	-3,672	USD	91
2015-01-01 to 2015-03-31	-5,582	USD	90

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	92	USD	91
2015-01-01 to 2015-03-31	144	USD	90

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	80	USD	91
2015-01-01 to 2015-03-31	287	USD	90

Inspect the source

Entity: PROTECT PHARMACEUTICAL Corp / CIK 0001493526
Captured: 2026-09-23 02:52 UTC
SEC response SHA-256: bf1ce86f3a2d5eb5f9d9f7f0fbe211675520a0792f638ea498f1809d5f6f06c8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001493526.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))